De novo abnormalities identified by fluorescence in situ hybridization during follow-up confer poor prognosis in Chinese multiple myeloma
BackgroundAlthough there is evolving consensus to re-evaluate cytogenetic features during follow-up in multiple myeloma (MM), longitudinal studies on cytogenetic evolution in Chinese MM patients are still lacking. Our aim was to highlight the importance of ongoing monitoring of cytogenetic character...
Saved in:
| Main Authors: | Shumin Chen, Lu Gao, Lin Feng, Zheng Wang, Ye Li, Qing Liu, Wenjie Song, Shu Kong, Yang Liu, Jin Lu, Yingjun Chang, Xiaojun Huang, Yueyun Lai |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-03-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1536825/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk adapted therapy for newly diagnosed multiple myeloma delivered through local cytogenetic laboratories in a National Clinical Trial: UKMRA RADAR study
by: Dipal Mehta, et al.
Published: (2025-06-01) -
A comprehensive analysis of bone marrow-derived cytogenetic abnormalities in multiple myeloma patients with extramedullary disease
by: Juan Xu, et al.
Published: (2025-05-01) -
A new prognostic scoring system for newly diagnosed multiple myeloma in the era of new drugs
by: Ye Li, et al.
Published: (2024-10-01) -
MULTIPARAMETRIC FLOW CYTOMETRY REFINES RISK STRATIFICATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS
by: Francesca Fazio, et al.
Published: (2023-08-01) -
Cytogenetic risk stratification combined with minimal residual disease status influences the therapeutic outcome and prognosis of multiple myelomas
by: Jianping Mao, et al.
Published: (2025-04-01)